Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study. J of Skin [Internet]. 2021 Nov. 5 [cited 2026 May 9];5(6):s44. Available from: https://skin.dermsquared.com/skin/article/view/1395